Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)

Mark Peyrot, Donald M Bushnell, Jennie H Best, Mona L Martin, Ann Cameron, Donald L Patrick, Mark Peyrot, Donald M Bushnell, Jennie H Best, Mona L Martin, Ann Cameron, Donald L Patrick

Abstract

Background: This study evaluated the measurement properties of a newly developed instrument - the Self-Management Profile for Type 2 Diabetes (SMP-T2D).

Methods: The 18-item SMP-T2D assesses 12 constructs: level and perceived ease of performance in five self-care domains (blood glucose monitoring, medication-taking, healthy eating, being physically active, and coping), and two global constructs (ease of weight management, confidence with ability to manage diabetes). Validation analyses were based on two studies involving 240 patients with T2D, Study 1 (Clinicaltrials.gov #NCT00637273) with SMP-T2D administration supplemented by SMP-T2D retest one week later, and Study 2 (Clinical trials.gov #NCT00877890) with SMP-T2D administration supplemented by 24-week SMP-T2D follow-up after medication change. Validation included clinical indicators and measures of patient reported quality of life, psychological well-being and treatment outcomes.

Results: All multi-item SMP-T2D measures showed acceptable internal consistency (alphas = 0.71 to 0.87); ten measures had test-retest reliability >0.75. Correlations among SMP-T2D measures and between SMP-T2D measures and validation measures, which were as hypothesized, provided evidence of convergent and discriminant validity. Scores for six SMP-T2D measures improved significantly during Study 2. Multiple regression analysis showed independent associations between change in SMP-T2D measures and change in trial outcomes from baseline to end-of-study.

Conclusions: Two studies provide preliminary evidence regarding the reliability, validity and responsiveness of the SMP-T2D. Further research on the utility of the instrument is needed.

References

    1. Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM, Weinger K, Weiss MA. National standards for diabetes self-management education. Diabetes Care. 2007;30:1630–1637. doi: 10.2337/dc07-9923.
    1. US Dept. of Health and Human Services Food and Drug Administration. Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims. 2009. .
    1. Mulcahy K, Maryniuk M, Peeples M, Peyrot M, Tomky D, Weaver T, Yarborough P. Diabetes self-management education core outcomes measures: Technical review. Diabetes Educ. 2003;29:768–803. doi: 10.1177/014572170302900509.
    1. Mulcahy K, Maryniuk M, Peeples M, Peyrot M, Tomky D, Weaver T, Yarborough P. AADE position statement - standards for outcomes measurement of diabetes self-management education. Diabetes Educ. 2003;29:804–816.
    1. Tomky D, Cypress M, Dang D, Maryniuk M, Peyrot M, Mensing C. AADE position statement: AADE 7 self-care behaviors. Diabetes Educ. 2008;34:445–449.
    1. Peyrot M, Peeples M, Tomky D, Charron-Prochownic D, Weaver T. Development of the American Association of Diabetes Educators’ Diabetes Self-Management Assessment Report Tool. Diabetes Educ. 2007;33:818–826. doi: 10.1177/0145721707307614.
    1. Charron-Prochownik D, Zgibor JC, Peyrot M, Peeples M, McWilliams J, Koshinsky J, Noullet W, Siminerio LM. on behalf of the Diabetes Education Outcomes Project Team. The Diabetes Self-Management Assessment Report Tool (D-SMART): Process evaluation and patient satisfaction. Diabetes Educ. 2007;33:833–839. doi: 10.1177/0145721707307613.
    1. Zgibor JC, Peyrot M, Ruppert K, Noullet W, Siminerio LM, Peeples M, McWilliams J, Koshinsky J, DeJesus C, Emerson S, Charron-Prochownik D. on behalf of the Diabetes Education Outcomes Project Team. Using the AADE outcomes system to identify patient behavior change goals and diabetes educator responses. Diabetes Educ. 2007;33:840–843.
    1. Toobert DJ, Hampson SE, Glasgow RE. The Summary of Diabetes Self-care Activities Measure. Diabetes Care. 2000;23:943–950. doi: 10.2337/diacare.23.7.943.
    1. Glasgow RE, McCaul KD, Schafer LC. Barriers to regimen adherence among persons with insulin-dependent diabetes. J Behav Med. 1986;9:65–77. doi: 10.1007/BF00844645.
    1. Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA. How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services? Diabetes Care. 2003;26:738–743. doi: 10.2337/diacare.26.3.738.
    1. Peyrot M, Rubin RR. Behavioral and psychosocial interventions in diabetes: A conceptual review. Diabetes Care. 2007;30:2433–2440. doi: 10.2337/dc07-1222.
    1. Wallston KA, Rothman RL, Cherrington A. Psychometric properties of the perceived diabetes self-management scale (PDSMS) J Behav Med. 2007;30:395–401. doi: 10.1007/s10865-007-9110-y.
    1. Anderson RM, Funnell MM, Fitzgerald JT, Marrenero DG. The Diabetes Empowerment Scale. Diabetes Care. 2000;23:739–743. doi: 10.2337/diacare.23.6.739.
    1. Trauer T, Mackinnon A. Why are we weighting? The role of importance ratings in quality of life measurement. Qual Life Res. 2001;10:579–585. doi: 10.1023/A:1013159414364.
    1. Muhr T. Atlas.ti computer aided text interpretation and theory building. User's manual. Berlin: Scientific Software Development; 1994.
    1. Jenkins CR, Dillman DA. In: Survey measurement and process quality. Lyberg LE, Biemer P, Collins M, DeLeeuw E, Dippo C, Schwarz N, editor. New York: John Wiley and Sons; 1997. Towards a theory of self-administered questionnaire design; pp. 165–196.
    1. Willis G. Cognitive Interviewing: A How-to guide. National Cancer Institute: Guides and reports for questionnaire design and testing; 1999.
    1. Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The Rapid Assessment of Physical Activity (RAPA) among older adults. Prev Chronic Dis. 2006;3:1–8. doi: 10.1191/1479972306cd086ed.
    1. Bergenstal RM, Wysham C, MacConell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE. DURATION-2 Study Group. Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet. 2010;376:431–439. doi: 10.1016/S0140-6736(10)60590-9.
    1. Best JH, Rubin RR, Peyrot M, Yan P, Malloy J, Garrison LP. Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared to sitagliptin or pioglitazone after 26 weeks of treatment. Diabetes Care. 2011;34:314–319. doi: 10.2337/dc10-1119.
    1. MacConell L, Malloy J, Huang W, Cirincione B, Shen L, Porter L. Safety and efficacy of once monthly exenatide administration over 20 weeks in patients with type 2 diabetes. Diabetologia. 2011;54(Supp 1):S38.
    1. Kind P. In: Quality of life and pharmacoeconomics in clinical trials. 2. Spilker B, editor. Philadelphia: Lippincott-Raven Publishers; 1996. The EuroQol instrument: an index of health-related quality of life; pp. 191–201.
    1. Peyrot M, Rubin RR, Chen X, Frias JP. Associations between improved glucose control and patient reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2011;13:471–476. doi: 10.1089/dia.2010.0167.
    1. Kolotkin RL, Crosby RD, Kosloski KD, Williams GR. Development of a brief measure to assess quality of life in obesity. Obes Res. 2001;9:102–111. doi: 10.1038/oby.2001.13.
    1. Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter. 2004;32:15–16.
    1. Bradley C. In: Handbook of psychology and diabetes. A guide to psychological measurement in diabetes research and practice. Chur BC, Bradley C, editor. Chur: Harwood Academic Publishers; 1994. Diabetes treatment satisfaction questionnaire (DTSQ) pp. 111–132.
    1. SPSS Inc. SPSS for Windows, Rel. 11.5.0. Chicago: SPSS Inc; 2002.
    1. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334. doi: 10.1007/BF02310555.
    1. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill; 1994.
    1. Cohen J, Cohen P, West S, Aiken L. Applied multiple regression/correlation analysis for the behavioral sciences. 3. Hillsdale: Lawrence Erlbaum Associates; 2003.
    1. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582–592.
    1. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205. doi: 10.1023/A:1015291021312.
    1. Peyrot M, Rubin RR. How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference. Diabetes Care. 2009;32:1411–1417. doi: 10.2337/dc08-2256.
    1. Peyrot M, Rubin R. Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: A model of patients’ cognitive framework. Patient Prefer Adherence. 2011;5:255–265.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir